iris has evolved

this is Pebble

portable | molecular | real-time | unique
The innovative molecular diagnostic device for rapid testing at the Point-of-Care.
get it now
pebble device

Pebble

Technology description

Pebble is a compact device for performing real-time colorimetric LAMP (qcLAMP). Pebble was created using three-dimensional (3D) additive manufacturing technology and operates via an Android application. The device can be used to extract rapidly quantitative information at a wide dynamic range of RNA or DNA template. Detection can occur from purified nucleic acids or directly from crude samples (swabs, saliva and biopsy tissue).
View more

validated for :

COVID-19
and Flu A

BRAF V600E
and CYP2C19*2
mutations

Food &
plant
pathogens

key features

Sample-to-answer in 15 to 30 min

Quantitative

User-friendly

Lightweight

Low power consumption

Smartphone controlled

Connected

Affordable to all

biopix-t

The company behind Pebble


Our vision

Our vision is to become an innovation leader in the field of molecular diagnostics and grow into an international company with significant global presence.

Our mission

Our mission is to offer portable diagnostic devices to every potential end-user, regardless of financial status, geographical location and training. Doctors, healthcare providers and patients in both the developed and developing countries will benefit equally from our technology, which intends to alleviate personal suffering and control disease outbreaks.
Discover more

news

BIOPIX-T launches its portable molecular diagnostic device “PEBBLE” with the COVID19 test for the point of care!

At BIOPIX-T we are pleased to announce that the portable molecular diagnostic platform “PEBBLE” and its compatible diagnostic test for the detection of Coronavirus are now commercially available! The “PEBBLE qcLAMP Platform“, as its full name is, is the first Greek portable molecular diagnostic device based on LAMP technology (Isothermal PCR), which can be used at the Point-of-Care. It is notified to […]

read more

BIOPIX-T receives the ISO/IEC 27001:2013 certification and expands its ISO 13485:2016

BIOPIX-T (www.biopix-t.com ) is pleased to announce that its information security management system (ISMS) has been certified as per ISO/IEC 27001:2013 by DQS Hellas. Moreover, BIOPIX-T successfully audited for the extension of the scope of its ISO 13485:2016, also by DQS Hellas, to additionally include the “Technical Support” and also cover its new manufacturing premises. Our new certification as per ISO/IEC 27001:2013 confirms […]

read more

Eleven invests in the Greek biotech company BIOPIX-T

After the initial investment from Metavallon.vc, we are exited to be also included in the portfolio of Eleven Ventures, further broadening the institutional support we receive and our geographical footprint! On the investment in BIOPIX-T Valeri Petrov, Partner at Eleven Ventures explains: “BIOPIX-T is our first investment in Greece and the company fits perfectly in one of our […]

read more

BIOPIX-T CERTIFIED AS PER ISO 13485:2016

BIOPIX-T (www.biopix-t.com ) is pleased to announce that its quality management system (QMS) has been successfully certified as per ISO 13485:2016 requirements by DQS Hellas, with scope “Design and Development, Production, Storage and Distribution of nucleic acid amplification kits (COV19 qc LAMP kit and Flu A qc LAMP kit) and instruments (Pebble qc LAMP platform)”.  Our ISO 13485:2016 certification serves our mission to offer safe portable In-Vitro diagnostic medical devices […]

read more
more news